Fortress Biotech, Inc. (FBIO) Total liabilities 2016–2025
Fortress Biotech, Inc. (FBIO) total liabilities at each fiscal year-end, per SEC filings.
$123.4MFY2025 · since FY2016: $87.8M → $123.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $123.4M | -15.4% |
| FY2024 | $145.9M | -12.1% |
| FY2023 | $165.9M | -32.1% |
| FY2022 | $244.3M | +43.2% |
| FY2021 | $170.6M | +25.1% |
| FY2020 | $136.4M | -11.4% |
| FY2019 | $153.9M | +26.9% |
| FY2018 | $121.3M | -3.3% |
| FY2017 | $125.4M | +42.9% |
| FY2016 | $87.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIO financial trends
FBIO RevenueFBIO Net incomeFBIO Net marginFBIO Gross profitFBIO Gross marginFBIO Operating incomeFBIO Operating marginFBIO Operating cash flowFBIO Free cash flowFBIO Capital expendituresFBIO Return on equityFBIO Stock buybacksFBIO Dividends paidFBIO Total assetsFBIO Shareholders’ equityFBIO overview →